Dexmedetomidine inhibits abnormal muscle hypertrophy of myofascial trigger points via TNF-α/ NF-κB signaling pathway in rats

Myofascial pain syndrome (MPS) is a chronic pain disorder with inflammation-related primarily characterized by the presence of myofascial trigger points (MTrPs). Myocyte enhancer factor 2C (MEF2C) is involved in the occurrence of a variety of skeletal muscle diseases. However, it is not yet clear if...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Mingjian, Liu, Yu, Li, Xuan, Pei, Miao, Han, Mei, Qi, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669483/
https://www.ncbi.nlm.nih.gov/pubmed/36408215
http://dx.doi.org/10.3389/fphar.2022.1031804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669483/
https://www.ncbi.nlm.nih.gov/pubmed/36408215
http://dx.doi.org/10.3389/fphar.2022.1031804

Ejemplares similares